Please ensure Javascript is enabled for purposes of website accessibility
Taylor Carmichael

Taylor Carmichael

TMFSaintCroix

Taylor Carmichael is a former attorney and filmmaker. He's the author of a line of murder mysteries, including Whodidit in the Supreme Court? and Whodidit With a Senator? The majority of what he knows about stocks he learned right here at the Motley Fool.

Recent articles

GettyImages-1213186521

Novavax Will Seek a Combo Vaccine for Flu and COVID-19

The company has tasked a team of executives first with getting its flu vaccine candidate approved, and then with combining it with the coronavirus vaccine that it's developing.


GettyImages-901114270

The Top 2 Contrarian Stocks to Buy Right Now

The stocks of Amarin and Clean Energy Fuels are down 90% off their highs -- but both could bounce back in a big way.


GettyImages-102695956

2 Game-Changing Stocks That Are Better Buys Than Snowflake

These two companies are growing revenues faster than Snowflake, and they're way more profitable.


GettyImages-1212896092

EU Regulators Undertake Rolling Review of Pfizer and BioNTech Vaccine Candidate

Pfizer and BioNTech will share the data from their phase 3 clinical trial with the European Medicines Agency as it comes in.


GettyImages-1213603696

Will Big Pharma Acquire Novavax?

The value of this vaccine specialist has shifted dramatically because of the coronavirus.

Nanox

Nano-X Announces Live Demonstration of Its ARC Device

Stock rallies 37% on the news.


5e012f1028f11.image

Hibbett Sports Is Crushing It

The 75-year-old sports retailer is growing revenue by 75%.


GettyImages-465050849

Why Are People Shorting Nano-X?

After suffering two brutal short attacks, Nano-X stock has dropped 50% in a couple of weeks. Should investors flee, or is this actually a buying opportunity?


GettyImages-1169308396

Better Buy: Amazon vs. Ulta Beauty

Amazon's stock has walloped Ulta over the last few years. Will this dominance continue?


GettyImages-1189508174

Should Teladoc Be Worried About GoodRx?

Just days after its IPO, GoodRx already has a valuation that rivals that of Teladoc Health. Can the fast-growing upstart leverage its popularity to become the new king of virtual healthcare?

celciusheat-image

Will Celsius Be the Next Monster Beverage?

The stock of the high-flying drink is up 500% over the last year. How high can it go?


GettyImages-1210035440

3 Top Biotech Picks for 2025

The opportunity is vast for Ontrak, Nano-X Imaging, and Zymeworks.


GettyImages-1213508113

If You Invested $5,000 in Vaxart in the March Market Crash, This Is How Much You'd Have Today

Shares of the vaccine developer have shot up as it pursues a preventative COVID-19 treatment.


GettyImages-102695956

Grail, Backed by Jeff Bezos and Bill Gates, Files for IPO

The company seeks to detect cancer from a simple blood test.


GettyImages-1206597318

6 Companies Racing to Mass-Produce a Coronavirus Vaccine in 2021

These healthcare companies have had plenty of help in building the manufacturing capacity needed to produce billions of vaccine doses.

GettyImages-684058866

What Is Afterpay and Why Does Shopify Want Its Business?

Afterpay introduced the "buy now, pay later" model that has taken Australia by storm. Now Shopify is partnering with a competitor to take it on.


GettyImages-509541586

Why Farfetch Is Not Afraid of Amazon

Farfetch is the top dog and first mover in helping high fashion brands sell clothes online. Now Amazon wants a piece of that market.


GettyImages-1215770297

Why Novavax's Coronavirus Vaccine Might Be First to Market

The key variable in this race is not the phase 3 trial, but which company has enough positive data for an Emergency Use Authorization.


GettyImages-1210689410

These 5 Healthcare Stocks Are the Biggest Winners in 2020

It's not a surprise that all five of these stocks are engaged in the fight against the novel coronavirus.


GettyImages-1206597318

AstraZeneca Might Receive Emergency Use Authorization for Its Coronavirus Vaccine

One report suggests that the U.K.-based company might win the coronavirus vaccine race in the U.S.